1. Home
  2. GLUE vs KLTOW Comparison

GLUE vs KLTOW Comparison

Compare GLUE & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLUE
  • KLTOW
  • Stock Information
  • Founded
  • GLUE 2019
  • KLTOW N/A
  • Country
  • GLUE United States
  • KLTOW United States
  • Employees
  • GLUE N/A
  • KLTOW N/A
  • Industry
  • GLUE Biotechnology: Pharmaceutical Preparations
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GLUE Health Care
  • KLTOW Health Care
  • Exchange
  • GLUE Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • GLUE N/A
  • KLTOW N/A
  • IPO Year
  • GLUE 2021
  • KLTOW 2022
  • Fundamental
  • Price
  • GLUE $4.64
  • KLTOW $0.02
  • Analyst Decision
  • GLUE Buy
  • KLTOW
  • Analyst Count
  • GLUE 3
  • KLTOW 0
  • Target Price
  • GLUE $14.33
  • KLTOW N/A
  • AVG Volume (30 Days)
  • GLUE 818.0K
  • KLTOW N/A
  • Earning Date
  • GLUE 03-20-2025
  • KLTOW N/A
  • Dividend Yield
  • GLUE N/A
  • KLTOW N/A
  • EPS Growth
  • GLUE N/A
  • KLTOW N/A
  • EPS
  • GLUE N/A
  • KLTOW N/A
  • Revenue
  • GLUE $75,622,000.00
  • KLTOW N/A
  • Revenue This Year
  • GLUE N/A
  • KLTOW N/A
  • Revenue Next Year
  • GLUE $2.30
  • KLTOW N/A
  • P/E Ratio
  • GLUE N/A
  • KLTOW N/A
  • Revenue Growth
  • GLUE N/A
  • KLTOW N/A
  • 52 Week Low
  • GLUE $3.21
  • KLTOW N/A
  • 52 Week High
  • GLUE $12.40
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • GLUE 31.20
  • KLTOW N/A
  • Support Level
  • GLUE $6.12
  • KLTOW N/A
  • Resistance Level
  • GLUE $5.95
  • KLTOW N/A
  • Average True Range (ATR)
  • GLUE 0.57
  • KLTOW 0.00
  • MACD
  • GLUE -0.17
  • KLTOW 0.00
  • Stochastic Oscillator
  • GLUE 4.98
  • KLTOW 0.00

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

Share on Social Networks: